The basic helix-loop-helix protein Neurogenin3 specifies precursor cells of the endocrine pancreas during embryonic development, and is thought to be absent postnatally. We have studied Ngn3 expression during in vitro generation of beta-cells from adult rat exocrine pancreas tissue treated with epidermal growth factor and leukaemia inhibitory factor. This treatment induced a transient expression of both Ngn3 and its upstream activator hepatocyte nuclear factor 6. Inhibition of EGF and LIF signalling by pharmacological antagonists of the JAK2/STAT3 pathway, or knockdown of Ngn3 by RNA interference prevented the generation of new insulin-positive cells. This study demonstrates that in vitro growth factor stimulation can induce recapitulation of an embryonic endocrine differentiation pathway in adult dedifferentiated exocrine cells. This could prove to be important for understanding the mechanism of beta-cell regeneration and for therapeutic ex vivo neogenesis of beta cells. Keywords: neurogenin3; transdifferentiation; beta cell; pancreas; diabetes Abbreviations: CK20, cytokeratin 20; EGF, epidermal growth factor; eGFP, enhanced green fluorescent protein; Hnf6, hepatocyte nuclear factor 6; JAK2, Janus kinase 2; LIF, leukaemia inhibitory factor; Ngn3, neurogenin 3; Pdx1, pancreatic and duodenal homeobox 1; STAT3, signal transducer and activator of transcription 3
Introduction
There is currently a lot of interest in the development of a treatment for diabetes that is based on beta-cell replacement or regeneration. Beta-cells could be (re-)generated by stimulation of beta-cell replication and/or (trans-)differentiation of stem/progenitor cells. It has been demonstrated that, during adult life, beta-cell maintenance and compensatory growth in mice results primarily from proliferation of the pre-existing beta cells. 1 However, numerous reports of alternative sources of beta-cell 'neogenesis' in response to severe tissue injury have been described. [2] [3] [4] [5] [6] The pancreas is composed of exocrine tissue, comprising acinar and duct cells, and of endocrine tissue that contains beta-, alpha-, delta-and pancreatic polypeptide cells. A possible source of progenitor cells is the acinar cell population that is the most abundant in adult pancreas and is known to retain a remarkable plasticity both in vivo and in vitro. [7] [8] [9] Isolated acinar cells can undergo dedifferentiation in vitro whereby they lose their zymogen granules and gain a duct-like phenotype including expression of the duct cell marker cytokeratin20. 8, 10 External stimuli can induce a phenotypical switch in these cells towards a hepatocyte-like phenotype. 7 We have recently developed a model for in vitro beta-cell neogenesis based upon growth factor stimulation of dedifferentiated acinar pancreatic cells. 11 The molecular regulation of this transdifferentiation from acinar to beta cells is unknown at present. Although it is known that during pancreatic regeneration the exocrine population can dedifferentiate towards an embryonic-like state in vivo, 12 in vitro recapitulation of the pro-endocrine developmental pathway has not yet been described at the molecular level. During embryonic development both the exocrine and endocrine cell populations differentiate from a common endodermal progenitor 13, 14 under control of a hierarchy of transcription factors. During pancreatic specification it is well documented that the transient expression of the basic helixloop-helix transcription factor neurogenin3 (Ngn3) defines the endocrine precursor pool within the embryonic endoderm. 13 Lineage tracing studies have demonstrated that Ngn3-expressing cells exclusively give rise to endocrine cells 15 and targeted deletion of Ngn3 results in agenesis of all islet cells. 16 Additionally, ectopic expression of Ngn3 predestines embryonic endoderm to an endocrine fate. 13, [17] [18] [19] In adult pancreas, Ngn3 is no longer expressed, or it is expressed at very low level. 15 It is not known whether re-expression of Ngn3 occurs in adult cells during regeneration. The exact nature of the upstream activator of Ngn3 remains elusive, although Hnf6 has been proposed as a possible regulator of Ngn3. 20 Our present study shows that a transient reactivation of the embryonic transcription factor Ngn3 plays an important role in beta-cell neogenesis from adult acinar tissue. The expression of Ngn3 can be induced in the acinar cell population and is controlled by the JAK/STAT pathway.
granules and more than 90% of them are immunoreactive for the ductal marker CK20, most of the remaining cells being fibroblasts. Owing to pretreatment with alloxan, a well-known beta-cell toxin, the amount of insulin-immunoreactive beta cells present in these preparations is reduced to 0.370.1%. Cells were allowed to form adherent monolayer cultures and were treated with either control medium or medium supplemented with the growth factors EGF and LIF to induce betacell neogenesis during a period of 3 days as described.
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Ngn3 expression profile
In this model of beta-cell neogenesis, a gene profile analysis was performed using PCR, as to examine the effects of growth factors EGF and LIF on transdifferentiation of acinar exocrine cells to beta cells. It was therefore assessed whether the re-expression of the pro-endocrine pancreatic transcription factor Ngn3 contributes to the increase in number of beta cells seen in the growth factor-treated conditions. When the gene expression profile was analyzed by RT-PCR, Ngn3 mRNA was readily detectable in the growth factor-treated cultures, but was not detectable in normal rat pancreas, purified rat islets or exocrine cell aggregates with 30 cycles of PCR. However, low Ngn3 mRNA expression was detected in alloxan-treated cells cultured in control medium (Figure 1a) . mRNA for the beta-cell markers Pdx1 and insulin was only present following addition of EGF and LIF (not shown). Analysis using conventional PCR revealed a transient upregulation of Ngn3 (Figure 1b ). Before and 24 h after the addition of growth factors, both Pdx1 and insulin were undetectable while the expression of these beta-cell markers appeared within 48 h and became maximally expressed by 72 h following stimulation (Figure 1b) . The level of Ngn3 transcripts was quantified by real-time RT-PCR and found 4.7-fold (n ¼ 3; Po0.05) induced in alloxan-treated pancreatic exocrine cell culture as compared to pancreas. Ngn3 mRNA levels increased as early as 24 h after initiation of growth factor treatment ( Figure 1c) . As compared to alloxan-treated cell culture after 0 h of treatment, addition of EGF and LIF induced Ngn3 transcript levels, respectively, 2.3À, 10.5À and 4.1Àfold (n ¼ 3, Po0.05) after 24, 48, and 72 h of culture (Figure 2a ). Ngn3 protein expression was analyzed immunocytochemically on the monolayer cultures at 0 h (control) and 24 h, 48 h, 72 h, and 96 h after growth factor stimulation ( Figure 2b ). We could not detect Ngn3 immunoreactivity in control cultures without growth factors, at any time point and regardless of alloxan pretreatment. In growth factor-treated conditions, however, intense Ngn3 immunoreactivity was detected in part of the cells (4.7772.27%; n ¼ 3) as early as 24 h after addition of growth factors (Figure 2b ). At this stage, Ngn3 was predominantly detected in the cytoplasm (Figure 2c ), although few cells expressed nuclear Ngn3. When attempting to phenotypically identify these cells, we observed that about 5% of the Ngn3-positive cells coexpressed the ductal marker cytokeratin20 and about 10% coexpressed the epithelial marker b-catenin (not shown). At this point, there was no expression of the beta-cell markers Pdx1 and insulin. After 48 h of treatment, immunocytochemistry revealed a translocation of Ngn3 from the cytoplasm to the nucleus (Figure 2c ). At this time point, more than 85% of the Ngn3-positive cells showed nuclear staining and cells appeared in the culture that coexpressed Ngn3 and insulin (Figure 2c ). In all Ngn3 þ cells that coexpressed insulin (7.4 þ 1.1%, n ¼ 3; Po0.01), no cytoplasmic but only nuclear localization of the transcription factor was observed. None of the Ngn3 positive cells expressed cytokeratin20 or betacatenin at this time (not shown). During the following 24 h, all Ngn3 was translocated to the nucleus and all the Ngn3-positive cells also expressed insulin (Figure 2c ). Another 24 h later, Ngn3 protein had disappeared (not shown).
Ngn3 gene silencing
To investigate whether the observed transient re-expression of Ngn3 is required for the differentiation of insulin-expressing cells in our culture model, we developed a lentivirus containing Ngn3-specific siRNA 21 and eGFP as a reporter. Cells were 
Role of JAK/STAT-signalling in Ngn3 expression
We examined the contribution of EGF-and LIF-activated signal-transduction pathways to the induction of Ngn3, and subsequent insulin gene expression. LIF effects are mediated 22 Therefore, we analyzed the effect of Pp-YLKTK-mts, a potent inhibitor of STAT3 activation. 23 Inhibition of activated STAT3 resulted in 2.3-fold decreased Ngn3 transcript levels (Po0.05; n ¼ 3) (Figure 1b ) and in decreased numbers of Ngn3-immunopositive cells (0.1270.02% compared to 4.7870.28% in the absence of inhibitor; n ¼ 3; Po0.001) (Figure 4a ). After 72 h of STAT3-inhibitor treatment, the number of insulin-expressing cells is also strongly reduced (0.370.07% in the presence of inhibitor compared to 9.271.5% in the absence of inhibitor; n ¼ 3; Po0.01) (Figure 4b) .
The contribution of JAK activity to tyrosine phosphorylation of STAT3 was investigated by treatment of the cultures with the JAK inhibitor AG490. 24 A 24-h incubation with the inhibitor induced a marked reduction in Ngn3 transcript levels ( Figure 1b ) and protein expression following stimulation with EGF and LIF (4.7870.28% in control cells versus 0.5170.05% after AG490 treatment (n ¼ 3; Po0.01)) (Figure 4a ). Seventy-two hours after addition of AG490, the percentage of insulin positive cells was reduced from 9.271.5% to 1.170.1%, which corresponds to a 88% reduction in beta-cell neogenesis (Po0.01) (Figure 4b ).
As EGF-receptor (EGFR) signalling is at least partly responsible for the beta-cell neogenesis and may control the responsiveness of LIF-induced STAT3 activation, 25 the effect of AG1478, a selective antagonist of the EGFR 26 on growth factor-induced expression of Ngn3, Pdx1 and insulin was examined. Inhibition of EGFR signalling by AG1478 induced only a minor decrease in Ngn3 mRNA expression (Figure 1b) . However, the EGFR-inhibitor lowered the number of Ngn3-immunoreactive cells (Figure 4a 
Growth factor-induced upregulation of Hnf6
During embryonic development, the onecut transcription factor hepatocyte nuclear factor-6 (Hnf6) controls the expression of Ngn3. 20 Low amounts of Hnf6 transcript are detected by RT-PCR (28 cycles of amplification) in control cultures at days 5 and 8, whereas Hnf6 mRNA levels increased after stimulation by EGF and LIF together but not alone (Figure 1a) . The time dependence of Hnf6 expression was analyzed by qPCR at 0 h (control), 24 h, 48 h, and 72 h after addition of both growth factors. Hnf6 gene expression was 10-fold increased Figure 2a) . Growth factorinduced Hnf6 gene expression in cultures was markedly reduced in the presence of the inhibitor of STAT-activation Pp-YLKTK-mts (7.5-fold decrease at day 6 (Po0.01; n ¼ 3)) (Figure 1c ). In the presence of nicotinamide in the medium, an agent which was shown to delay the loss of exocrine cell markers, 8, 11 we found that 10-20% of all cells expressed Hnf6 in the nucleus. Sixty percent of these cells coexpressed CK20 and 45% coexpressed the acinar marker lipase (some Hnf6-positive cells expressed both CK20 and lipase) ( Figure 5 ). These observations support our hypothesis of a transdifferentiation from exocrine acinar to endocrine beta cells. 11 
Discussion
We have previously developed and validated an in vitro model for beta-cell regeneration by stimulation of dedifferentiated exocrine cells with a combination of EGF and LIF. 11 Upon treatment with both growth factors, an important increase in the absolute number of beta cells was seen (60-fold in 3 days). This could not have been due to beta-cell replication which was extremely low. Transitional stages of differentiation indicated that new beta cells arose from transdifferentiation of acinar cells. 11 A recent report confirmed this transdiffer- entiation phenomenon by genetic lineage tracing. 27 The present study aimed at understanding the molecular mechanism involved in this in vitro beta-cell neogenesis model. Studies on the embryonic development of the endocrine pancreas have shown that a transient expression of the basic helix-loop-helix transcription factor Ngn3 drives the proendocrine fate. 15, 16, 28 Ectopic expression of Ngn3 in adult exocrine ductal cells leads to a partial recapitulation of endocrine differentiation. 19 In normal pancreas, freshly isolated exocrine tissue and cultured exocrine cells, Ngn3 mRNA was absent. Our study demonstrates that stimulation of the exocrine cells with both EGF and LIF activated Ngn3 gene expression. Pre-existing beta cells were eliminated by the toxin alloxan, which also induced Ngn3 expression, be it at low level (sixfold lower when compared to the corresponding condition treated with EGF and LIF). In a separate experiment, cells were not pretreated with alloxan and in this case Ngn3 mRNA could no longer be detected unless EGF and LIF were both supplemented to these cultures (data not shown). Ngn3 protein expression was detected by immunocytochemistry, however, exclusively when EGF and LIF were both supplemented to the culture medium. Insulin mRNA and protein were undetectable in cells that were treated with alloxan only, but were readily detectable after treatment with growth factors. This is in accordance with our previous finding that neogenesis of insulin immunoreactive beta cells only occurs in the presence of both growth factors. 11 The observation that, in the absence of growth factors, alloxaninduced increase in Ngn3 mRNA expression is not mirrored by an increase in protein expression may be explained by the difference in sensitivity of the detection techniques. In addition, large discrepancies between mRNA and protein levels may exist in cells, but most studies on Ngn3 expression so far focused on its transcriptional regulation. Ngn3 protein was first detected by immunocytochemistry 24 h after treatment with EGF and LIF. At this time point, Ngn3 was mainly located in the cytoplasm, as has also been seen during embryonic development in rat at E15 (unpublished observations). Two days later, Ngn3 translocated to the nucleus, as it does during normal endocrine development. However, in contrast to the normal beta-cell development, during which Ngn3 and markers for differentiated beta cells like Pdx1 and insulin never are coexpressed, Ngn3 and insulin were observed together in the same cells between day 2 and 4 following treatment with EGF and LIF. 15, 29, 30 This is very unusual, since normally Ngn3 represses its own expression and thus activates the differentiation process, but does not complete it. 31 The temporary coexpression of Ngn3 and insulin in our in vitro model for beta-cell neogenesis is a striking difference with the expression pattern during embryogenesis of the endocrine pancreas which cannot be explained by our present data. The expression of Ngn3 could be prevented by inhibiting signal-transduction pathways involved in EGF and LIF signalling, namely by inhibiting EGFR, JAK2 and STAT3. This inhibition of Ngn3 subsequently led to a marked decrease in the beta-cell neogenesis normally seen after EGF þ LIF treatment. Inhibition of JAK/ STAT induced a stronger downregulation of Ngn3 than inhibition of the EGFR. This is in agreement with what has been described during neurogenesis, where it was found that EGF enhances the responsiveness of LIF-activated signal transduction, the effect being mediated by STAT3 phosphorylation. 25 To validate the requirement of Ngn3 in inducing the differentiation of insulin-positive cells we have set up a system to silence the Ngn3 gene expression using lentivirusmediated RNAi that targets Ngn3. RNAi is an efficient means to manipulate gene function 32, 33 and the use of a lentivirus allows for the transduction of non-cycling cells. 34 Control virus and virus that expressed the specific Ngn3 siRNA transduced the cells at same efficiency (B20%). However, no insulinpositive cells coexpressing eGFP could be found after transduction with LeNgn3-si1, whereas in controls 19% of the insulin-positive cells were labelled with the fluorescent reporter. This indicates that lentivirus-driven expression of this siRNA efficiently silenced Ngn3 gene expression in transduced cells and that silencing of Ngn3 expression prevents the neogenesis of beta cells.
The exact nature of the upstream activators of Ngn3 is still unclear, but it has been shown that the transcription factor Hnf6 controls the expression of Ngn3 during development, and that Hnf6 knockout mice still express Ngn3, but at reduced levels. 20 It is well described that Hnf6 is present in the acinar and ductal cells of the adult pancreas. 35 However, immunocytochemical analyses indicated that in our in vitro culture model, Hnf6-expression in the dedifferentiated exocrine cells could no longer be shown. After stimulation of our cultures with EGF and LIF, a transient upregulation of Hnf6 was detected, that immediately preceded the Ngn3 expression. It is possible that EGF þ LIF signalling via the JAK/STAT pathway upregulates Hnf6 which in turn induces the transient expression of Ngn3. It is known that Hnf6 gene expression can be upregulated by growth hormone treatment via activation of STAT5. 36 Hnf6 upregulation via STAT3 is not yet described, but after treatment of our cells with the selective inhibitor of STAT3 (Pp-YLKTK-mts), Hnf6 mRNA expression was decreased 10-fold as compared to controls. The observation of cells coexpressing Ngn3 and CK20, a marker of duct cells and dedifferentiated acinar cells, suggest that dedifferentiated acinar cells represent the progenitor cells that started to express Ngn3. Additionally, after treatment of the cultures with nicotinamide to delay the loss of acinar characteristics, 8, 11 we could detect Hnf6 protein expression in the nucleus of cells expressing CK20 and/or the acinar cell marker lipase. This confirms our hypothesis that acinar exocrine cells of the pancreas harbour a remarkable plasticity and can serve as endocrine progenitors. 11 In conclusion, we demonstrate that EGF and LIF signalling via the JAK/STAT pathway induces a transient re-expression of the embryonic pro-endocrine transcription factor Ngn3 in adult pancreatic cells. Adult beta-cell neogenesis in vitro at least partially recapitulates the embryonic molecular pathway by being dependent on reexpression of Ngn3.
Materials and Methods
Animals and isolation procedure
Male 10-12 week old Wistar rats (Janvier, Le Genest-St-Isle, France) weighing 250-300 g were used for the isolation of cells from the pancreas.
Pancreata were partially dissociated with collagenase and exocrine acini were purified by centrifugal elutriation as published before 8, 35 All animal experimentation was approved by the Ethical Committee of the Free University of Brussels. Cell Culture Exocrine cells were pre-cultured for 4 days in bacteriological Petri dishes (Nunc, Naperville, IL, USA) in suspension culture in RPMI-1640 Glutamax-I medium supplemented with 10% foetal bovine serum (FBS, Gibco BRL, Paisley, Scotland), penicillin (75 mg/l) (Continental Pharma, Brussels, Belgium) and antibiotics (Sigma, St Louis, MO, USA). Geneticin sulphate (50 mg/ml) (Sigma) was used to suppress fibroblasts from the culture. Medium was replaced daily during this preculture period. At the end of the preculture, cells were treated with alloxan (10 mM, Sigma) for 10 min at 371C to remove contaminating beta cells, and transferred to 24-well plates (Falcon, BD Biosciences, Erembodegem, Belgium) for adherent culture. Adherent monolayers were further cultured with RPMI supplemented with 1% FBS and antibiotics (controls). For growth factor stimulation of neogenesis this medium was supplemented with 50 ng/ml human recombinant epidermal growth factor (EGF) (Sigma, St Louis, MO) and 40 ng/ml recombinant mouse leukaemia inhibitory factor (LIF) (Sigma). 20 Signal transduction inhibition assays were performed using a selective EGFR inhibitor (AG1478, 10 mM, Sigma), a JAK2 inhibitor (AG490, 20 mM, Sigma) and a phospho-STAT3 inhibitor (Pp-YLKTK-mts, 2.5 mM, Calbiochem). Cell monolayers were analyzed after a culture period of 3 days in the latter media. At these concentrations, no toxic effects of the inhibitors were noted on the epithelial monolayers. Some cultures were treated with nicotinamide (10 mM) (Sigma) to partially prevent the loss of exocrine markers normally seen during the acino-ductal transdifferentiation. 8 
Immunocytochemistry
Immunocytochemical staining of the monolayers was performed directly in the 24-well plates. For this purpose, the cell monolayers were fixed for 10 min with 4% buffered formaldehyde followed by 20 min methanol (À201C) for cell permeabilization. Primary antibodies used in this study are polyclonal anti-insulin (C. Van Schravendijk, VUB, Brussels), 36, 37 polyclonal anti-rat C-peptide-I (O.D. Madsen, Hagedorn Research Institute, Gentofte, Denmark), 38 polyclonal anti-Pdx1 (O.D. Madsen) 8 , polyclonal anti-Ngn3, 16 monoclonal anti-cytokeratin-20 (CK20) (Novocastra, Newcastle-upon-Tyne, UK), 36, 37 monoclonal anti-b-catenin (BD Biosciences, Erembodegem, Belgium), 39 polyclonal anti-Hnf6 (Santa Cruz Biotechnology, CA, USA) 40 and polyclonal anti-lipase (Biodesign International, Maine, USA). Secondary antibodies conjugated with fluorescein isothiocyanate, tetramethylrodamine isothiocyanate or Cy5 (Jackson Immunoresearch, West Grove, PA) were used as described previously. 11 Imaging was performed using Zeiss Axiovision Software. RNA isolation, RT-PCR and qPCR total RNA was isolated from cells and tissues using the GenElute Mammalian Total RNA miniprep kit (Sigma). For the semi-quantitative analysis of transcripts encoding insulin, neurogenin3 (Ngn3), pancreatic and duodenal homeobox1 (Pdx1), hepatocyte nuclear factor-6 (Hnf6) and beta-actin, the total RNA was reversed transcribed and amplified as described by the manufacturer (Gibco BRL) with blanks in each assay. Primers were designed to anneal to specific sequences of rat insulin-5 0 : caatcatagaccatcagcaagc and insulin-3 0 : tttattcattgcagaggggtgg, NGN3-5 0 : gaaatggaaggtagtggaggca and NGN3-3 0 : agccagtgaggtaagacgcaac, PDX1-5 0 : ctcgctgggaacgctggaaca and PDX1-3 0 : ctttggtggatttcatccacgg, HNF-6-5 0 : aagccctggagcaaactcaa and HNF-6-3 0 : tctgtccttcccgtgttctt. Specific primers for control amplifications were beta-actin-5 0 : ccccattgaacacggcatt and beta-actin-3 0 : ggtcatcttttcacggttggc. The cycling profile was 1.5 min at 941C followed by 0.5 min at 941C, 0.5 min at 601C and 1 min at 721C for 10 cycles and 0.5 min at 941C, 0.5 min at 581C and 1 min at 721C for 16-20 cycles (total of 22 cycles for insulin, 28 cycles for HNF6, 30 cycles for NGN3, 32 cycles for PDX1 and 30 cycles for b-actin). Analysis of the amplified fragments was done on ethidium bromide-stained agarose gels. All analyses were performed at least three times. Target genes selected from RT-PCR were further analyzed using qPCR to quantify their expression level. cDNA was prepared from 500 ng total RNA following DNase treatment and 10 ng RNA equivalent used for PCR with selected primers in the presence of SYBR Green. A melt-curve analysis was performed for each reaction. The expression levels were normalized to individual beta-actin (internal control) and to normal rat pancreas (reference).
Lentivirus-mediated RNA interference Ngn3-specific RNAi target sequences were developed using dedicated software available through the Whitehead Institute for Biomedical Research website (http:// jura.wi.mit.edu/bio/). 37 Corresponding oligo DNA molecules (Eurogentec) were cloned in the BglII and HindIII sites of the pSuper.basic vector (Oligoengine). Insert-containing clones were PCR-selected and sequenced. DNA from clones containing correct inserts was EcoRI-ClaI cut, which released a DNA fragment containing the H1 promoter and the cloned oligo duplex, which was subsequently subcloned in the EcoRI-ClaI sites of the pLVTHM vector. 21 Screening for RNAi activity of the constructs was performed as follows: 293 T cells were plated at 70% confluency in 24-well plates at day 0. After allowing the cells to attach, 500 ng DNA of the appropriate pLVTHM constructs was transfected per well. A measure of 100 ng pAdTrackCMV-HA-mmNgn3 plasmid DNA was transfected per well the following day. The latter construct encodes HA-tagged mouse Ngn3 (Heremans et al., 2003) . After an additional 24 h, cells were processed for Western-blot analysis, in which 10 mg total protein was used per lane. In these assays, the Ngn3 protein was detected using an anti-HA tag antibody (Sigma). Constructs that displayed sufficient RNAi activity were used for lentivirus generation according to standard techniques. 21 Two constructs, Ngn3-si1 and Ngn3-si2, were selected for further use in Ngn3 RNAi experiments, generating lentivirus LeNgn3-si1 and LeNgn3-si2, respectively. The Ngn3-si1 target sequence is gtgctcagttccaattcca, and the Ngn3-si2 target sequence is gaccctgcgcttcgcccac. The selected target sequences match 100% with both mouse and rat Ngn3 mRNA sequences. Negative control RNAi constructs were scrambled1 (gag catgcgagccatgcac) and scrambled2 (TCGTCATAGCGTGCATAGG). Primairy acinar exocrine cells were transduced at 19.472.2% efficiency after infection with LeScrambled2, at 20.171.5% efficiency after infection with LeNgn3-si1 and at 20.271.5% efficiency after infection with LeNgn3-si2 (n ¼ 4) statistics We used a two-tailed, paired Student's t-test and considered statistical significance at a confidence interval o0.05. Mean values are given7S.E.M. Number of independent experiments is indicated in the text.
